Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yutiq in Glaucoma Tube Implant Surgery
NCT04918121Phase 1Active, not recruiting
- Start
- Jul 2021
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of fluocinolone in Glaucoma (2 arms). Primary endpoints: Change in Intraocular Pressure (Goldman applanation tonometry) at 36 months, Change in Intraocular Pressure (Tonopen/Icare) at 36 months and 2 more. Started Jul 2021; status: active, not recruiting.
02
Drugs
fluocinolone
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT04918121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04918121.